How to Help Your Patients Find Aurovela 1/20 21 Day in Stock: A Provider's Guide

Your Patients Are Struggling to Find Their Birth Control — Here's How You Can Help

Patients on Aurovela 1/20 21 Day (Norethindrone Acetate 1 mg/Ethinyl Estradiol 20 mcg) are increasingly reporting difficulty filling their prescriptions at local pharmacies. While this medication is not in a formal shortage, real-world availability has been inconsistent enough that patients are calling your office for help.

This guide provides practical, actionable steps you and your clinical staff can take to help patients maintain uninterrupted access to their oral contraceptives. Every recommendation is designed to integrate into existing workflows with minimal disruption.

Current Availability of Aurovela 1/20 21 Day

Aurovela 1/20 21 Day is manufactured by Aurobindo Pharma and is currently in active production. It is not listed on the FDA or ASHP drug shortage databases as of early 2026.

However, availability varies significantly by:

• Region: Some areas have consistent supply; others do not.
• Pharmacy type: Chain pharmacies may not stock Aurovela if their formulary agreements favor a different generic. Independent pharmacies tend to have more flexible sourcing.
• Insurance formulary: Insurance plan preferences influence which generics pharmacies keep on shelves.

For a detailed overview of the supply situation, see our provider shortage briefing.

Why Patients Can't Find Aurovela 1/20 21 Day

Understanding the root causes helps you counsel patients and adjust your prescribing approach:

Pharmacy Stocking Algorithms

Large pharmacy chains use automated systems to determine inventory levels. If demand for Aurovela at a specific location drops below a threshold — even temporarily — the system may reduce or eliminate reorders. Patients then find their pharmacy "no longer carries" it.

Formulary-Driven Stocking

Insurance formulary preferences heavily influence pharmacy inventory. If the dominant insurance plans in your area prefer Junel 1/20 or Microgestin 1/20 over Aurovela, pharmacies will stock those brands instead. Patients with plans that prefer Aurovela may find themselves caught in the middle.

Distributor Supply Variability

Even when Aurobindo is manufacturing at full capacity, regional distribution patterns can create localized shortages. Wholesalers allocate inventory based on historical ordering data, which can lag behind actual demand.

Patient Timing

Patients who wait until the last day of their current pack to seek a refill have no buffer if their pharmacy is out. This turns a supply inconvenience into a care gap.

What Providers Can Do: 5 Actionable Steps

Step 1: Write Flexible Prescriptions

The single most impactful change you can make is writing prescriptions that maximize pharmacy flexibility:

• Use the generic name: Prescribe as "Norethindrone Acetate/Ethinyl Estradiol 1 mg/20 mcg, 21-day or 28-day pack" rather than specifying "Aurovela."
• Allow substitution: Ensure the "Dispense As Written" (DAW) box is not checked. Allow the pharmacist to fill with whichever AB-rated equivalent is in stock.
• Include alternatives: In your e-prescribing comments, consider noting: "Aurovela 1/20, Junel 1/20, Microgestin 1/20, or equivalent acceptable."

Step 2: Use Medfinder to Identify Available Pharmacies

Medfinder for Providers provides real-time stock data for pharmacies in your patient's area. Before sending a prescription, you or your staff can:

1. Search for Aurovela 1/20 21 Day on Medfinder
2. Enter the patient's zip code
3. Identify pharmacies with current stock
4. Route the prescription to an in-stock pharmacy

This takes seconds and prevents the back-and-forth of rejected or unfilled prescriptions.

Step 3: Proactively Address Substitution Concerns

When you know a patient may face difficulty finding Aurovela specifically, address it during the visit:

• Explain that Junel 1/20, Microgestin 1/20, and Blisovi Fe 1/20 contain the exact same active ingredients at the exact same doses
• Reassure them that all are AB-rated bioequivalent by the FDA
• Note that minor differences in inactive ingredients (fillers, dyes) rarely cause clinical differences
• Document the conversation and authorization for substitution in the chart

Step 4: Establish Quick-Response Protocols for Your Staff

Create a streamlined workflow for when patients call reporting they can't fill their prescription:

1. Check Medfinder for nearby pharmacies with stock
2. Transfer the prescription to an in-stock pharmacy (or send a new e-prescription)
3. If no stock anywhere: Escalate to the prescriber for an alternative medication recommendation
4. Document: Note the substitution or change in the patient's chart

Empower medical assistants and front-desk staff to handle steps 1-2 without requiring prescriber involvement, using pre-approved substitution protocols.

Step 5: Educate Patients on Self-Service Tools

Equip patients to solve availability issues independently whenever possible:

• Direct them to Medfinder to check pharmacy stock in their area
• Recommend they refill 7-10 days before running out to allow time for pharmacy sourcing
• Suggest they consider telehealth contraceptive services (Pandia Health, Nurx, The Pill Club) as backup options
• Share relevant patient education articles:
• How to find Aurovela 1/20 21 Day in stock
• Alternatives to Aurovela 1/20 21 Day
• How to check pharmacy stock

Therapeutically Equivalent Alternatives

All of the following contain norethindrone acetate 1 mg/ethinyl estradiol 20 mcg and are AB-rated as therapeutically equivalent:

• Junel 1/20 (Teva) — 21-day and Fe 28-day packs available. Cash price: $15-$40; coupon price: $8-$15.
• Microgestin 1/20 (Mayne Pharma) — 21-day and Fe 28-day packs. Cash price: $20-$45; coupon price: $9-$15.
• Blisovi Fe 1/20 (Lupin) — 28-day pack only. Cash price: $20-$50; coupon price: $10-$20.
• Larin 1/20 (Novitium) — 21-day and Fe 28-day packs. Cash price: $15-$35; coupon price: $8-$15.
• Hailey 1/20 (Glenmark) — 28-day pack with iron tablets. Cash price: $20-$40; coupon price: $10-$18.

If patients require a different oral contraceptive class entirely, consider discussing options such as Yaz (drospirenone/ethinyl estradiol) or Lo Loestrin Fe (lower-dose estrogen). For detailed alternative profiles, see our alternatives guide.

Workflow Integration Tips

• EHR templates: Create a prescription template for norethindrone acetate/ethinyl estradiol 1 mg/20 mcg that includes substitution authorization and preferred alternatives in the comments field.
• Staff training: Brief clinical staff on the availability situation and the Medfinder provider tool so they can handle patient calls efficiently.
• Visit integration: At annual well-woman visits or contraceptive counseling appointments, proactively discuss the availability landscape and confirm the patient's pharmacy still stocks their brand.
• Follow-up flags: For patients on Aurovela 1/20, consider adding a chart flag to prompt availability counseling at future visits.

Final Thoughts

Helping patients find their birth control shouldn't be this complicated, but the reality of the current generic market means it sometimes is. By writing flexible prescriptions, using tools like Medfinder, establishing quick-response protocols, and educating patients on self-service options, you can minimize care gaps and reduce the administrative burden on your practice.

For the broader shortage context and prescribing considerations, see our companion briefing on the Aurovela 1/20 21 Day shortage for providers. And for cost-saving strategies to share with patients, see our guide on helping patients save money on Aurovela 1/20 21 Day.